Clinical Trials in Atlanta

Showing 13721-13740 of 19,805 trials

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01812005

This phase II trial studies how well alisertib with and without rituximab works in treating patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving alisertib with and without rituximab may be an effective treatment for B-cell non-Hodgkin lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+8 more

Ohio State University Comprehensive Cancer Center14 participantsStarted May 2013

Atlanta, Georgia, United States • Columbus, Ohio, United States

TERMINATEDNA< 1 mile

Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant

NCT00784043

The purpose of this study is to evaluate and document longitudinal efficacy in young children implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant systems.

Hearing Loss

Med-El Corporation37 participantsStarted Mar 2004

Jacksonville, Florida, United States • Atlanta, Georgia, United States • Cleveland, Ohio, United States +6 more locations

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant

Find Trials by Condition in Atlanta

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

ATLAS: Ambulatory Treatments for Leakage Associated With Stress

Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Thrombolysis in Pediatric Stroke (TIPS)

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS

Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD

OLIF25™ /OLIF51™ Study

Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures

Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer

Phoenix Exoskeleton for SCI Users